A Review on Simultaneous Estimation of combination of Omeprazole and Domperidone in Bulk and Tablet by RP-HPLC Method

Author:

R. R. Tanpure1,M. H. Kolhe1,G. S. Shinde2,R. J. Bhor1

Affiliation:

1. Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy, Loni, Pravaranagar, Tal - Rahata, Dist. Ahmednagar (MH) - 413736, India.

2. Department of Pharmaceutics, Institute of Pharmacy, Loni KD, Tal - Rahata, Dist. Ahmednagar (MH) - 413736, India.

Abstract

The main objective of the given study is that to develop and validate stability indicating reverse phase HPLCmethod for the simultaneous estimation of combined Omeprazole and domperidone in solid dosage forms. The method was optimized Shimadzu RP-LC (HPLC) system with a SPD 10A UV detector (BDS C18 column (250×4.6mm I.D Hypersil). methanol and ammonium acetate buffer (60:40). Methanol is used as diluents. The flow rate is 1ml/min and the effluent is monitor at 280nm. Results: The retention time of combined Omeprazole and domperidone was 6.75min. and 9.64min. respectively. The proposed method study was simple, precise,rapid, accurate and. It was economical and suitable for continuous determination of combined Omeprazole and domperidone in pharmaceutical dosage form. For RP-HPLC, separation of components were achieved at a Phenomenex Rp‐C18 column. The components detected by UV detection at range of 295nm. Thus, the evaluation method is applicable for regular determination of combined omeprazole and domperidone in pharmaceutical formulations.The drugs were placed to different adverse conditions like acid, base, neutral hydrolysis, oxidation, and photo-degradation. The validation of developed method was successfully applied to the simultaneous evaluation of combined omeprazole and domperidone by Reverse Phase-High Performance Liquid Chromatography. Report by RP-HPLC were good assumed.

Publisher

A and V Publications

Reference17 articles.

1. Indian Pharmacopoeia. Vol. 1, The Controller of Publications, Delhi, 1996, 532.

2. The United States Pharmacopoeia, Vol. XXIV, Supplement 7, The U.S. Pharmacopoeia Convention, Inc. Rockville, MD, 2000.

3. National Center for Biotechnology Information (2021). PubChem Compound Summary for CID3151, Domperidone. Retrieved, at December 15, 2021 From https://pubchem.ncbi.nlm.nih.gov/compound/Domperidone.

4. Kumar PV. Chandra BC. et al Development and validation of new analytical method for the simultaneous estimation of omeprazole and domperidone in pharmaceutical dosage form by UV spectrophotometer. International Journal of Research in Pharmaceutical Chemistry and Analysis. 2019; 1(2). http://dx.doi.org/10.33974/ijrpca.v1i2.63

5. Strand DS. Kim D. Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut and liver. 2017; 11(1): 27-37.https://doi.org/10.5009/gnl15502

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3